Sovah Health has agreed to pay $4.36 million to settle federal claims that the hospital system violated the Controlled Substances Act between 2017 and 2020. As part of the resolution Sovah Health further agreed to be subject to a period of four years of increased compliance and oversight. Federal prosecutors say one Sovah employee diverted over 11,000 controlled substance pills while another tampered with fentanyl vials and hydromorphone injectables by replacing the controlled substance with saline.